126 related articles for article (PubMed ID: 15945061)
1. Methylphenidate analogs with behavioral differences interact differently with arginine residues on the dopamine transporter in rat striatum.
Volz TJ; Bjorklund NL; Schenk JO
Synapse; 2005 Sep; 57(3):175-8. PubMed ID: 15945061
[TBL] [Abstract][Full Text] [Related]
2. L-arginine increases dopamine transporter activity in rat striatum via a nitric oxide synthase-dependent mechanism.
Volz TJ; Schenk JO
Synapse; 2004 Dec; 54(3):173-82. PubMed ID: 15452864
[TBL] [Abstract][Full Text] [Related]
3. Covalent and noncovalent chemical modifications of arginine residues decrease dopamine transporter activity.
Volz TJ; Kim M; Schenk JO
Synapse; 2004 Jun; 52(4):272-82. PubMed ID: 15103693
[TBL] [Abstract][Full Text] [Related]
4. A triple mutation in the second transmembrane domain of mouse dopamine transporter markedly decreases sensitivity to cocaine and methylphenidate.
Chen R; Han DD; Gu HH
J Neurochem; 2005 Jul; 94(2):352-9. PubMed ID: 15998286
[TBL] [Abstract][Full Text] [Related]
5. Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.
Storch A; Hwang YI; Gearhart DA; Beach JW; Neafsey EJ; Collins MA; Schwarz J
J Neurochem; 2004 May; 89(3):685-94. PubMed ID: 15086525
[TBL] [Abstract][Full Text] [Related]
6. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of methylphenidate analogues and their binding affinities at dopamine and serotonin transport sites.
Davies HM; Hopper DW; Hansen T; Liu Q; Childers SR
Bioorg Med Chem Lett; 2004 Apr; 14(7):1799-802. PubMed ID: 15026075
[TBL] [Abstract][Full Text] [Related]
8. Mercuric chloride and p-chloromercuriphenylsulfonate exert a biphasic effect on the binding of the stimulant [3H]methylphenidate to the dopamine transporter.
Schweri MM
Synapse; 1994 Mar; 16(3):188-94. PubMed ID: 8197581
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacology of 6-substituted benztropines: discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter.
Simoni D; Rossi M; Bertolasi V; Roberti M; Pizzirani D; Rondanin R; Baruchello R; Invidiata FP; Tolomeo M; Grimaudo S; Merighi S; Varani K; Gessi S; Borea PA; Marino S; Cavallini S; Bianchi C; Siniscalchi A
J Med Chem; 2005 May; 48(9):3337-43. PubMed ID: 15857139
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of scopolamine on in vivo binding of dopamine transporter and vesicular monoamine transporter radioligands in rat brain.
Kilbourn MR; Kemmerer ES; Desmond TJ; Sherman PS; Frey KA
Exp Neurol; 2004 Aug; 188(2):387-90. PubMed ID: 15246838
[TBL] [Abstract][Full Text] [Related]
11. The interaction of methylphenidate and benztropine with the dopamine transporter is different than other substrates and ligands.
Dar DE; Mayo C; Uhl GR
Biochem Pharmacol; 2005 Aug; 70(3):461-9. PubMed ID: 15950948
[TBL] [Abstract][Full Text] [Related]
12. Environmental enrichment decreases cell surface expression of the dopamine transporter in rat medial prefrontal cortex.
Zhu J; Apparsundaram S; Bardo MT; Dwoskin LP
J Neurochem; 2005 Jun; 93(6):1434-43. PubMed ID: 15935059
[TBL] [Abstract][Full Text] [Related]
13. Effects of methylphenidate analogues on phenethylamine substrates for the striatal dopamine transporter: potential as amphetamine antagonists?
Wayment HK; Deutsch H; Schweri MM; Schenk JO
J Neurochem; 1999 Mar; 72(3):1266-74. PubMed ID: 10037500
[TBL] [Abstract][Full Text] [Related]
14. Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter.
Gnegy ME; Khoshbouei H; Berg KA; Javitch JA; Clarke WP; Zhang M; Galli A
Mol Pharmacol; 2004 Jul; 66(1):137-43. PubMed ID: 15213305
[TBL] [Abstract][Full Text] [Related]
15. Unraveling neuronal dopamine transporter mechanisms with rotating disk electrode voltammetry.
Schenk JO; Wright C; Bjorklund N
J Neurosci Methods; 2005 Apr; 143(1):41-7. PubMed ID: 15763135
[TBL] [Abstract][Full Text] [Related]
16. Synaptosomal dopamine uptake in rat striatum following controlled cortical impact.
Wilson MS; Chen X; Ma X; Ren D; Wagner AK; Reynolds IJ; Dixon CE
J Neurosci Res; 2005 Apr; 80(1):85-91. PubMed ID: 15704194
[TBL] [Abstract][Full Text] [Related]
17. Interaction of cocaine and dopamine transporter inhibitors on behavior and neurochemistry in monkeys.
Ginsburg BC; Kimmel HL; Carroll FI; Goodman MM; Howell LL
Pharmacol Biochem Behav; 2005 Mar; 80(3):481-91. PubMed ID: 15740791
[TBL] [Abstract][Full Text] [Related]
18. Enhanced dopamine uptake in the striatum following repeated restraint stress.
Copeland BJ; Neff NH; Hadjiconstantinou M
Synapse; 2005 Sep; 57(3):167-74. PubMed ID: 15945060
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic innervation of the human striatum in Parkinson's disease.
Porritt M; Stanic D; Finkelstein D; Batchelor P; Lockhart S; Hughes A; Kalnins R; Howells D
Mov Disord; 2005 Jul; 20(7):810-8. PubMed ID: 15726582
[TBL] [Abstract][Full Text] [Related]
20. Psychostimulants and vesicle trafficking: a novel mechanism and therapeutic implications.
Hanson GR; Sandoval V; Riddle E; Fleckenstein AE
Ann N Y Acad Sci; 2004 Oct; 1025():146-50. PubMed ID: 15542712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
